BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

QuatRx Pharmaceuticals 

777 East Eisenhower Parkway
Suite 100
Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-913-9900 Fax: 734-913-0743


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Shionogi & Co., Ltd. Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals To Market Ospemifene 3/2/2010 9:46:15 AM
QuatRx Pharmaceuticals Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) 9/10/2009 8:14:54 AM
QuatRx Pharmaceuticals Announces Further Positive Phase 3 Results For Ophena(TM) (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy 7/29/2009 8:46:26 AM
QuatRx Pharmaceuticals Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3/31/2009 8:24:05 AM
QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 9/24/2008 8:59:43 AM
QuatRx Pharmaceuticals Initiates Second Phase 3 Study of Ophena(TM) in Women With Postmenopausal Vaginal Syndrome 9/4/2008 8:56:19 AM
QuatRx Pharmaceuticals Presents Results From Ophena(TM) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 6/16/2008 7:50:29 AM
QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 1/4/2008 8:05:07 AM
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) 1/3/2008 7:50:12 AM
QuatRx Pharmaceuticals Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome 8/22/2007 8:57:17 AM
123